少动鞘氨醇单胞菌临床感染分析及药敏监测  

Clinical infection and bacterial resistance surveillance of Sphingomonas paucimobilis

作　　者：赵渊[1] 佘军[1] 顾保罗[1] 

机构地区：[1]杭州市萧山区第一人民医院,浙江杭州311200

出　　处：《健康研究》2009年第4期263-265,共3页Health Research

摘　　要：目的分析医院少动鞘氨醇单胞菌(sphingomonas paucimobilis S.paucimobilis)感染的临床分布及耐药性。方法对本院近3.5年分离出的少动鞘氨醇单胞菌的临床分布特点及耐药情况进行回顾性分析。结果2006年1月-2009年5月本院共分离出121株少动鞘氨醇单胞菌,菌株来源主要为痰液、血液及腹水,分别占60.3%、9.1%及7.4%;菌株主要分布于ICU、呼吸科及普外科;少动鞘氨醇单胞菌对亚胺培南及氨基糖苷类抗菌药敏感性较高。结论少动鞘氨醇单胞菌在一定条件下可引起呼吸道、血液等的感染,氨基糖苷类抗菌药及亚胺培南可作为治疗少动鞘氨醇单胞菌的首选用药。Objective To investigate the clinical infectious distribution caused by S.paucimobilis and its antimicrobial resistance in our hospital.Methods Drug resistance situation and clinical specimen distribution of S.paucimobilis isolated from our hospital in the recent 3.5 years was analyzed retrospectively.Results Totally 121 strains of S.paucimobilis were isolated from Jan 2006 to May 2009,and the percentages of these strains obtained from sputum,blood and ascites were 60.3 %,9.1% and 7.4 %,respectively;The strains of S.paucimobilis mainly distributed in ICU,Respiratory ward and General surgery ward.S.paucimobilis was more sensitive to aminoglycosides and imipenem.Conclusion S.paucimobilis can cause respiratory tract and blood infection under certain conditions,and aminoglycosides and imipenem may be the first choice to treat infections caused by S.paucimobilis.

关 键 词：少动鞘氨醇单胞菌 耐药性 医院感染 

分 类 号：R378[医药卫生—病原生物学]